EU opinion & policy debates - across languages | BlogActiv.eu

Archives for pharmaceuticals

What is the difference between the risk-based regulatory approach and a hazard-based one? Why is it that hazard-based activists are so successful in pushing such an unrealistic approach?

I wrote a number of blogs on the apparent change of policy on transparency by the European Medicines Agency when it published a new draft policy for targeted consultation last May – see here, here, and here for example. The Management Board of the agency were due to decide on this changes in June but… » read more

EurActiv Network